Flomics

About:

Flomics mines the nucleic acids in your fluids to create affordable, non-invasive and accurate diagnostics

Description:

Flomics uses circulating transcriptomic analysis to provide novel non-invasive, fast and affordable diagnostics for complex diseases.

Total Funding Amount:

1M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2018-01-01

Contact Email:

info(AT)flomics.com

Founders:

Esther Lizano, João Curado, Luis Korrodi, Nuno Alves

Number of Employees:

11-50

Last Funding Date:

2022-03-28

IPO Status:

Private

Industries: